Literature DB >> 31970185

Calcitonin-negative neuroendocrine tumor of the thyroid with metastasis to liver-rare presentation of an unusual tumor: A case report and review of literature.

Huai-Jie Cai1, Han Wang1, Nan Cao1, Bin Huang1, Fan-Lei Kong2, Li-Ren Lu2, Ya-Yuan Huang2, Wei Wang3.   

Abstract

BACKGROUND: Neuroendocrine tumors mainly occur in the stomach, intestine, pancreas, and lung and are rarely detected in the thyroid. Thyroid neuroendocrine tumors, designated medullary thyroid carcinoma, generally present with elevated calcitonin. Calcitonin-negative neuroendocrine tumors of the thyroid are extremely rare. CASE
SUMMARY: Here, we present a case report of a 56-year-old female patient with a neck pain complaint. Total thyroidectomy was conducted after comprehensive evaluation, and diagnosis was confirmed as calcitonin-negative neuroendocrine tumor of the thyroid. Two months later, liver metastasis was detected, and transcatheter arterial chemoembolization was subsequently performed to control growth. However, the curative effect was unsatisfactory and multiple intrahepatic metastases occurred after 3 mo.
CONCLUSION: Owing to the rarity of this disease, no clear guidelines are available for treatment. In addition to reporting this rare case, we have reviewed and summarized associated medical literature with an aim to provide a comprehensive reference platform for subsequent research. ©The Author(s) 2020. Published by Baishideng Publishing Group Inc. All rights reserved.

Entities:  

Keywords:  Case report; Diagnosis; Hepatic metastases; Neuroendocrine tumor; Thyroid; Treatment

Year:  2020        PMID: 31970185      PMCID: PMC6962086          DOI: 10.12998/wjcc.v8.i1.179

Source DB:  PubMed          Journal:  World J Clin Cases        ISSN: 2307-8960            Impact factor:   1.337


  28 in total

1.  Calcitonin-negative neuroendocrine tumor of the thyroid: a distinct clinical entity.

Authors:  Victoriya S Chernyavsky; Saima Farghani; Tomer Davidov; Ly Ma; Nicola Barnard; Louis F Amorosa; Stanley Z Trooskin
Journal:  Thyroid       Date:  2011-02       Impact factor: 6.568

2.  Usefulness of EUS combined with contrast-enhancement in the differential diagnosis of malignant versus benign and preoperative localization of pancreatic endocrine tumors.

Authors:  Takuya Ishikawa; Akihiro Itoh; Hiroki Kawashima; Eizaburo Ohno; Hiroshi Matsubara; Yuya Itoh; Yosuke Nakamura; Masanao Nakamura; Ryoji Miyahara; Kazuhiko Hayashi; Masatoshi Ishigami; Yoshiaki Katano; Naoki Ohmiya; Hidemi Goto; Yoshiki Hirooka
Journal:  Gastrointest Endosc       Date:  2010-05       Impact factor: 9.427

3.  Expression of thyroid transcription factor-1 (TTF-1) in human C cells and medullary thyroid carcinomas.

Authors:  R Katoh; E Miyagi; N Nakamura; X Li; K Suzuki; K Kakudo; M Kobayashi; A Kawaoi
Journal:  Hum Pathol       Date:  2000-03       Impact factor: 3.466

4.  Contrast harmonic EUS for the prediction of pancreatic neuroendocrine tumor aggressiveness (with videos).

Authors:  Maxime Palazzo; Bertrand Napoléon; Rodica Gincul; Mathieu Pioche; Bertrand Pujol; Christine Lefort; Fabien Fumex; Vincent Hautefeuille; Monique Fabre; Jérome Cros; Michèle Felce; Anne Couvelard; Alain Sauvanet; Philippe Lévy; Philippe Ruszniewski; Laurent Palazzo
Journal:  Gastrointest Endosc       Date:  2018-01-08       Impact factor: 9.427

5.  A Calcitonin Non-producing Neuroendocrine Tumor of the Thyroid Gland.

Authors:  Atsuko Kasajima; José Cameselle-Teijeiro; Lourdes Loidi; Yoshio Takahashi; Noriaki Nakashima; Satoko Sato; Fumiyoshi Fujishima; Mika Watanabe; Tadao Nakazawa; Hiroshi Naganuma; Tetsuo Kondo; Ryohei Kato; Hironobu Sasano
Journal:  Endocr Pathol       Date:  2016-12       Impact factor: 3.943

6.  Normal preoperative calcitonin levels do not always exclude medullary thyroid carcinoma in patients with large palpable thyroid masses.

Authors:  A H Redding; S N Levine; M R Fowler
Journal:  Thyroid       Date:  2000-10       Impact factor: 6.568

7.  Medullary thyroid cancer with undetectable serum calcitonin.

Authors:  Erika F Brutsaert; Adam J Gersten; Andrew B Tassler; Martin I Surks
Journal:  J Clin Endocrinol Metab       Date:  2014-12-09       Impact factor: 5.958

Review 8.  Normal perioperative serum calcitonin levels in patients with advanced medullary thyroid carcinoma: case report and review of the literature.

Authors:  José Miguel Dora; Maria Heloisa Busi da Silva Canalli; Clarissa Capp; Márcia Khaled Puñales; José Gilberto H Vieira; Ana Luiza Maia
Journal:  Thyroid       Date:  2008-08       Impact factor: 6.568

9.  Radiation-associated small cell neuroendocrine carcinoma of the thyroid: a case report with molecular analyses.

Authors:  Zhanna Mussazhanova; Shiro Miura; Boban Stanojevic; Tatiana Rougounovitch; Vladimir Saenko; Toshio Shiraishi; Tomomi Kurashige; Kazuko Shichijo; Kenichi Kaneko; Haruo Takahashi; Masahiro Ito; Masahiro Nakashima
Journal:  Thyroid       Date:  2014-01-15       Impact factor: 6.568

10.  Metastasis of colon cancer to the thyroid and cervical lymph nodes: a case report.

Authors:  Shigeki Minami; Keiji Inoue; Junji Irie; Takashi Mine; Nobuhiro Tada; Masataka Hirabaru; Kazumasa Noda; Shinichiro Ito; Masashi Haraguchi
Journal:  Surg Case Rep       Date:  2016-10-07
View more
  2 in total

1.  Disruption of Cell-Cell Communication in Anaplastic Thyroid Cancer as an Immunotherapeutic Opportunity.

Authors:  Sanjukta Chakraborty; Michelle Carnazza; Tara Jarboe; Nicole DeSouza; Xiu-Min Li; Augustine Moscatello; Jan Geliebter; Raj K Tiwari
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Calcitonin negative medullary thyroid cancer in ectopic thyroid tissue: a rare diagnosis in an unusual location.

Authors:  Gareth Montgomery; Laurence Collins; Caroline Coghlin; Ramzan Ullah
Journal:  BMJ Case Rep       Date:  2020-08-18
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.